Newsfeed

Bei diesem Bereich handelt es sich um eine mögliche Darstellungsform der Integration von Nachrichtenquellen mit Bezug zu börsennotierten Unternehmen.
Als Präsentationsebene fungiert ein Template, dass an Kurznachrichtenservices angelehnt ist, bei dem sich Nutzer einen schnellen Überblick über aktuelle Nachrichten verschaffen können. Die Detailansichten ermöglichen bei Interesse weitergehende Recherchen.

Dieser Newsfeed ist eine Zusammenstellung aktueller Nachrichten, die aus Direktanbindungen von TopTier NewsWire-Services mit Bezug zu börsennotierten Unternehmen stammen. Dieser Feed hier dient ausschließlich Demonstrationszwecken. Sektoren-spezifische Nachrichten, Public Relations sowie Produktinformationen können über die GICS Portale > Bereich Sektor-Intelligence abgerufen werden.

CA74143C1068
Filter zurücksetzen
Do you already know our new terminal view? Click here.
FIGI: BBG00DYKFCQ8
PREV
PreveCeutical Medical Inc.
GICS: Health Care · SECTOR: EQTY · SUB-SECTOR: Biotechnology · THEMEFOLIO: $HLTH
NAME
PreveCeutical Medical Inc.
ISIN
CA74143C1068
TICKER
PREV
MIC
XCNQ
REUTERS
PREV.CD
BLOOMBERG
PREV CN
Di., 04.08.2026       Preveceutical Medical
CA74143C1068

Vancouver, British Columbia--(Newsfile Corp. - August 4, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical"), is pleased to announce that, further to its news releases dated July 27, 2026, June 12, 2026, May 12, 2026 and April 22, 2026 (the "Prior News Releases"), it has closed a fo...
Zur Nachricht
Preveceutical Medical
Charts & Research Termsheets Terminal
Permalink
Mo., 27.07.2026       Preveceutical Medical
CA74143C1068

Vancouver, British Columbia--(Newsfile Corp. - July 27, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical"), is pleased to announce that, further to its news releases dated June 12, 2026, May 12, 2026 and April 22, 2026, it has closed a third tranche (the "Third Tranche") of its pre...
Zur Nachricht
Preveceutical Medical
Charts & Research Termsheets Terminal
Permalink
Fr., 12.06.2026       Preveceutical Medical
CA74143C1068

Vancouver, British Columbia--(Newsfile Corp. - June 12, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical"), is pleased to announce that, further to its news releases dated May 12, 2026 and April 22, 2026, it has closed a second tranche (the "Second Tranche") of its previously annou...
Zur Nachricht
Preveceutical Medical
Charts & Research Termsheets Terminal
Permalink
Mo., 08.06.2026       Preveceutical Medical
CA74143C1068

Vancouver, British Columbia--(Newsfile Corp. - June 8, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) ("PreveCeutical"), a health sciences company that develops innovative options for preventive and curative therapies utilizing organic and nature-identical products, today announced that BioGene Therapeutics Inc. (the "Com...
Zur Nachricht
Preveceutical Medical
Charts & Research Termsheets Terminal
Permalink
Mi., 20.05.2026       Preveceutical Medical
CA74143C1068

Vancouver, British Columbia--(Newsfile Corp. - May 19, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical"), is pleased to announce that, further to its news releases dated May 12, 2026 and April 22, 2026, it has extended the closing of its private non-brokered private placement (the...
Zur Nachricht
Preveceutical Medical
Charts & Research Termsheets Terminal
Permalink
Di., 12.05.2026       Preveceutical Medical
CA74143C1068

Vancouver, British Columbia--(Newsfile Corp. - May 12, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical"), is pleased to announce that, further to its news release dated April 22, 2026, it has closed an initial tranche (the "Initial Tranche") of its previously announced $1,000,000...
Zur Nachricht
Preveceutical Medical
Charts & Research Termsheets Terminal
Permalink
Mi., 22.04.2026       Preveceutical Medical
CA74143C1068

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVancouver, British Columbia--(Newsfile Corp. - April 22, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical"), is pleased to announce a non-brokered private placement (the "Offering") of up to 40,0...
Zur Nachricht
Preveceutical Medical
Charts & Research Termsheets Terminal
Permalink
Mi., 01.04.2026       Preveceutical Medical
CA74143C1068

Vancouver, British Columbia--(Newsfile Corp. - April 1, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCID: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical") announces that it has elected to rely on Coordinated Blanket Order 51-933 and move to semi-annual financial reporting ("SAR"). Coordinated Blanket Order 51-93 allows eligible ventu...
Zur Nachricht
Preveceutical Medical
Charts & Research Termsheets Terminal
Permalink
Mo., 30.03.2026       Preveceutical Medical
CA74143C1068

Vancouver, British Columbia--(Newsfile Corp. - March 30, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) ("PreveCeutical" or the "Company"), a health sciences company that develops innovative options for preventive and curative therapies utilizing organic and nature-identical products, is pleased to announce the appointmen...
Zur Nachricht
Preveceutical Medical
Charts & Research Termsheets Terminal
Permalink
Do., 12.03.2026       Preveceutical Medical
CA74143C1068

Vancouver, British Columbia--(Newsfile Corp. - March 12, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H0) ("PreveCeutical"), a health sciences company that develops innovative options for preventive and curative therapies utilizing organic and nature-identical products, today announced that BioGene Therapeutics Inc. (the "Co...
Zur Nachricht
Preveceutical Medical
Charts & Research Termsheets Terminal
Permalink
Silent Ad
Mi., 25.02.2026       Preveceutical Medical
CA74143C1068

Vancouver, British Columbia--(Newsfile Corp. - February 25, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical") is pleased to announce that the Canadian Patent Office has allowed Canadian Patent Application No. 3127020, titled "A Cyclic Peptide", which relates to the Company's pain...
Zur Nachricht
Preveceutical Medical
Charts & Research Termsheets Terminal
Permalink
Mo., 09.02.2026       Preveceutical Medical
CA74143C1068

Vancouver, British Columbia--(Newsfile Corp. - February 9, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical") is pleased to announce it has filed an International (PCT) patent application on February 5, 2026, having the application no. PCT/US2026/014110, and entitled "Delivery...
Zur Nachricht
Preveceutical Medical
Charts & Research Termsheets Terminal
Permalink
Do., 04.12.2025       Preveceutical Medical
CA74143C1068

Vancouver, British Columbia--(Newsfile Corp. - December 4, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCID: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical")  is pleased to announce that the Australian Patent Office has granted Australian Patent No. AU2020212659, titled "A Cyclic Peptide", which relates to the Company's pai...
Zur Nachricht
Preveceutical Medical
Charts & Research Termsheets Terminal
Permalink